Pfizer Inc. announced the election of Mortimer ('Tim') J. Buckley, former Chairman and Chief Executive Officer at Vanguard, to its Board of Directors, effective immediately. Mr. Buckley will also join the Governance and Sustainability Committee and the Audit Committee of Pfizer’s Board.
Mr. Buckley's appointment follows a comprehensive search that began in May 2024. His extensive expertise in global investment management, financial markets, and operations is expected to be a valuable asset to Pfizer and its shareholders.
The addition of Mr. Buckley, a widely respected business leader, brings the total number of directors to 14, with 13 being independent. This move comes as Pfizer faces pressure from activist investor Starboard Value, and the appointment may be seen as a step to enhance corporate governance and address shareholder concerns.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.